U.S. Physical Therapy, Inc. (NYSE:USPH) Q4 2022 Earnings Conference Call February 23, 2023 10:30 AM ET Company Participants Christopher Reading - President and CEO Jake Martinez - SVP and Controller Carey Hendrickson - CFO Eric Williams - Co-COO Graham Reeve - Co-COO Rick Binstein - EVP and General Counsel Conference Call Participants Brian Tanquilut - Jefferies Larry Solow - CJS Securities Matt Larew - William Blair Mike Petusky - Barrington Research Operator Good day and thank you for standing by. Welcome ...

U.S. Physical Therapy, Inc. (NYSE:USPH) Q3 2022 Earnings Conference Call November 3, 2022 10:30 AM ET Company Participants Christopher Reading - President, CEO & Director Jake Martinez - SVP, Finance & Accounting Carey Hendrickson - CFO Graham Reeve - COO, West Conference Call Participants Brian Tanquilut - Jefferies Madeline Mollman - William Blair & Company Michael Petusky - Barrington Research Operator Good day, everyone, and welcome to the U.S. Physical Therapy Third Quarter 2022 Earnings Conference Cal ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2022 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) TEXAS 77042 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE) REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (713) 297-7000 | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | | --- | --- | --- | | Common Stock, $.01 par value | USPH | New Y ...

U.S. Physical Therapy, Inc. (NYSE:USPH) Q2 2022 Earnings Conference Call August 4, 2022 10:30 AM ET Company Participants Chris Reading - President and Chief Executive Officer Carey Hendrickson - Chief Financial Officer Eric Williams - Co-Chief Operating Officer Graham Reeves - Co-Chief Operating Officer Rick Binstein - Executive Vice President and General Counsel Johnny Blanchard - Assistant Controller Conference Call Participants Larry Solow - CJS Securities Steph Wissink - Jefferies Michael Petusky - Barr ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM _____TO _____ COMMISSION FILE NUMBER 1-11151 U.S. PHYSICAL THERAPY, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) NEVADA 76-0364866 (STATE OR OT ...

Financial Data and Key Metrics Changes - The company reported operating results per share of $0.65 for Q1 2022, compared to $0.64 in Q1 2021 [17] - Adjusted EBITDA reached an all-time high of $17.9 million, a 14.2% increase from the previous year [17][22] - Total company revenue grew by 17.2% for the quarter, with Physical Therapy revenue increasing by 10.6% to $110.4 million [12][22] Business Line Data and Key Metrics Changes - Physical Therapy patient volumes per day per clinic reached 27.9, a record high for Q1, up 3% from 27.1 in the previous year [18] - Injury Prevention (IP) revenues increased by 90% to $19.1 million, with a 22.4% increase excluding the recent acquisition [11][22] - Same-store visit growth was reported at 5.9% for the quarter [9][21] Market Data and Key Metrics Changes - The net rate for Physical Therapy operations was $103, down from $104.72 in Q1 2021, reflecting Medicare rate cuts [20] - Total visits increased by almost 116,000 to 1,063,519, a 12.2% increase from the previous year [21] Company Strategy and Development Direction - The company is focused on growth through acquisitions and has opened 12 de novo facilities so far this year [14][30] - Management emphasized the importance of partnerships and the ability to withstand challenges in the healthcare environment [14][32] - The company is actively pursuing negotiations with private insurance providers to improve reimbursement rates [44] Management's Comments on Operating Environment and Future Outlook - Management noted a strong recovery in March following a slow start to the year due to the Omicron variant and winter weather [8] - The company expects to continue growing volumes and is optimistic about future performance despite ongoing challenges [38] - Management highlighted the competitive landscape, indicating potential market share gains from struggling competitors [91] Other Important Information - Operating costs were $105.1 million, representing 79.8% of net revenues, with salaries and related costs slightly up year-over-year [23][24] - The company ended the quarter with $118 million drawn on its revolving credit facility, maintaining a strong balance sheet [30] Q&A Session Summary Question: Volume growth expectations for Q2 and beyond - Management believes they can continue to grow volumes but avoids specific quarter-to-quarter guidance [38] Question: Impact of Medicare rate cuts - Management confirmed that further Medicare rate cuts are expected in Q2 and Q3 [40] Question: Negotiations with private insurance providers - Management is actively working on negotiations with private insurers for better rates, acknowledging the challenges [44] Question: Margin impacts from labor and rent costs - The increase in contract labor costs was attributed to early-year challenges, with expectations for margins to improve in subsequent quarters [47] Question: Growth in the Injury Prevention business - Management indicated that while growth was strong, it was slightly below internal expectations due to industry-specific challenges [76] Question: Competitive environment and market share - Management noted that they have likely gained market share from hospitals and smaller practices during the pandemic [91] Question: Future acquisition strategy - Management is optimistic about ongoing acquisition discussions, seeing both larger and smaller opportunities in the market [75]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 1-11151 U.S. PHYSICAL THERAPY, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) NEVADA 76-0364866 (STATE OR OTHER JURISDICTION ...

U.S. Physical Therapy, Inc. (NYSE:USPH) Q4 2021 Earnings Conference Call February 24, 2022 10:30 AM ET Company Participants Christopher Reading - President and Chief Executive Officer Jon Bates - VP and Controller Carey Hendrickson - Chief Financial Officer Eric Williams - Chief Operating Officer, East Graham Reeve - COO West Conference Call Participants Lawrence Solow - CJS Securities Stephanie Wissink - Jefferies Madeline Mollman - William Blair Operator Good day, everyone and welcome to the U.S. Physica ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM _____TO _____ COMMISSION FILE NUMBER 1-11151 U.S. PHYSICAL THERAPY, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) (STATE OR OTHER JURISDICTI ...

U.S. Physical Therapy, Inc. (NYSE:USPH) Q3 2021 Earnings Conference Call November 4, 2021 10:30 AM ET Company Participants Chris Reading - President and Chief Executive Officer Carey Hendrickson - Chief Financial Officer Jon Bates - Controller Conference Call Participants Larry Solow - CJS Securities Mike Petusky - Barrington Research Operator Good day and thank you for standing by. Welcome to the U.S. Physical Therapy Third Quarter 2021 Earnings Conference Call. [Operator Instructions] I’d now like to turn ...